IDO1 and neoplasm: The combination of an IDO1 inhibitor (BGB-5777 or 1-methyl-tryptophan), PD-1 blockade and irradiation significantly increased OS and resulted in long-term tumor control in 30–40% of mice with advanced GB [749,750].